MichaelW.BeckerMDCell Therapy

PubMed

• Diagnosing familial platelet disorder with predisposition to myeloid malignancy: Lessons learned from a germline whole-gene deletion of RUNX1.
  John A Cliburn, Jann C Uy, Sharon Swift, Jane L Liesveld, M Anwar Iqbal, Audrey N Jajosky, Michael W Becker> ;International Journal of Laboratory Hematology. 2024 Feb 1
• 1 citations
  Vitamin D Receptor Antagonist MeTC7 Inhibits PD-L1.
  Negar Khazan, Emily R Quarato, Niloy A Singh, Cameron W A Snyder, Taylor Moore, John P Miller, Masato Yasui, Yuki Teramoto, Takuro Goto, Sabeeha Reshi, Jennifer Hong, ...> ;Cancers. 2023 Jun 30
• Mitochondrial Transfer to Host Cells from Ex Vivo Expanded Donor Hematopoietic Stem Cells.
  Hiroki Kawano, Yuko Kawano, Chen Yu, Mark W LaMere, Matthew J McArthur, Michael W Becker, Scott W Ballinger, Satoshi Gojo, Roman A Eliseev, Laura M Calvi> ;Cells. 2023 May 25
• 1 citations
  Referral to and receipt of allogeneic hematopoietic stem cell transplantation in older adults with acute myeloid leukemia.
  Dharmini Manogna, Jodi J Lipof, Andrea M Baran, Bassil Said, Michael W Becker, Jason H Mendler, Omar S Aljitawi, Kristen M O'Dwyer, Eric Huselton, Richard Burack, Marg...> ;Journal of Geriatric Oncology. 2023 Jan 1
• 2 citations
  Protocol for a pilot randomized controlled trial of a mobile health exercise intervention for older patients with myeloid neoplasms (GO-EXCAP 2).
  Kah Poh Loh, Chandrika Sanapala, Michelle Janelsins, Heidi D Klepin, Rebecca Schnall, Eva Culakova, Michael B Sohn, Paula Vertino, Martha Susiarjo, Marielle Jensen-Bat...> ;Journal of Geriatric Oncology. 2022 May 1
• 6 citations
  A phase II study of sequential decitabine and rapamycin in acute myelogenous leukemia.
  Jane L. Liesveld, Andrea Baran, Mitra Azadniv, Haley Misch, Katherine Nedrow, Michael W. Becker, Kah Poh Loh, Kristen M. O'Dwyer, Jason H. Mendler> ;Leukemia Research. 2022 Jan 1
• 3 citations
  Portable Medical Orders and End of Life Measures in Acute Myeloid Leukemia and Myelodysplastic Syndromes.
  Marissa Locastro, Andrea Baran, Jane L. Liesveld, Eric Huselton, Michael W. Becker, Kristen M. O'Dwyer, Omar S. Aljitawi, Megan Baumgart, Eric Snyder, Benzi M. Kluger,...> ;Blood Advances. 2021 Sep 15
• 3 citations
  Oral white lesion in patients post-hematopoietic stem cell transplantation: a case series demonstrating the diagnostic dilemma.
  Tatsiana Pukhalskaya, Bruce R. Smoller, Michael Becker, Alexander Maly, Yehuda Zadik, Sharon Elad> ;Supportive Care in Cancer. 2021 Jul 4
• 6 citations
  Speckle-tracking echocardiography in comparison with ejection fraction for prediction of cardiovascular mortality in patients with end-stage renal disease.
  Janna Terhuerne, Merel van Diepen, Rafael Kramann, Johanna Erpenbeck, Friedo W. Dekker, Nikolaus Marx, Jürgen Floege, Michael Becker, Georg Schlieper> ;Clinical Kidney Journal. 2021 May 28
• 38 citations
  Scaffold-mediated CRISPR-Cas9 delivery system for acute myeloid leukemia therapy
  Tzu-Chieh Ho, Hye Sung Kim, Yumei Chen, Yamin Li, Mark W. LaMere, Caroline Chen, Haiyan Wang, Jing Gong, Cal D. Palumbo, John M. Ashton, Hae-Won Kim, Qiaobing Xu, Mich...> ;Science Advances. 2021 May 1
• 2 citations
  Dynamic handgrip exercise for the evaluation of mitral valve regurgitation: an echocardiographic study to identify exertion induced severe mitral regurgitation.
  Mhd Nawar Alachkar, Annemarie Kirschfink, Julian Grebe, Mohammad Almalla, Michael Frick, Andrea Milzi, Wiebke Moersen, Michael Becker, Nikolaus Marx, Ertunc Altiok> ;The International Journal of Cardiovascular Imaging. 2021 Mar 1
• 4 citations
  Dual-center experiences with interventional closure of patent foramen ovale: A medium-term follow-up study comparing two patient groups aged under and over 60 years.
  Dejan Nachoski, Joerg Schroeder, Mohammad Almalla, Ralf Kubini, Vadim Tchaikovski, Christoph Kosinski, Michaël De Becker, Ali Aljalloud> ;Clinical Cardiology. 2021 Feb 17
• 8 citations
  Genomic and evolutionary portraits of disease relapse in acute myeloid leukemia.
  Franck Rapaport, Yaseswini Neelamraju, Timour Baslan, Duane C. Hassane, Agata Gruszczynska, Marc Robert de Massy, Noushin Farnoud, Samuel Haddox, Tak C. Lee, Juan S. M...> ;Leukemia. 2021 Feb 12
• A large co-operative biological and clinical study to better understand and improve treatment of the rare t(8;16)(p11;p13) acute myeloid leukaemia
  Michael W. Becker, Emanuele Angelucci> ;British Journal of Haematology. 2021 Feb 4
• 18 citations
  Treatment decision-making in acute myeloid leukemia: a qualitative study of older adults and community oncologists
  Kah Poh Loh, Maya Abdallah, Sindhuja Kadambi, Megan Wells, Anita J. Kumar, Jason H. Mendler, Jane L. Liesveld, Marsha N. Wittink, Kristen M. O'Dwyer, Michael W. Becker...> ;Leukemia & Lymphoma. 2021 Jan 28
• 99 citations
  Chemotherapy Induces Senescence-Like Resilient Cells Capable of Initiating AML Recurrence.
  Cihangir Duy, Meng Li, Matt Teater, Cem Meydan, Francine E. Garrett-Bakelman, Tak C. Lee, Christopher R. Chin, Ceyda Durmaz, Kimihito Cojin Kawabata, Eugen Dhimolea, C...> ;Cancer Discovery. 2021 Jan 26
• 2 citations
  Patient-Derived Xenografts from Solid Tumors (PDX) for Models of Metastasis
  Annika Wulf-Goldenberg, Jens Hoffmann, Michael Becker, Bernadette Brzezicha, Wolfgang Walther> ;Methods in Molecular Biology. 2021 Jan 1
• 25 citations
  Barriers to Hematopoietic Cell Transplantation for Adults in the United States: A Systematic Review with a Focus on Age.
  Colin Flannelly, Jian Liang Tan, Colin McHugh, Chandrika Sanapala, Tara Lagu, Jane L. Liesveld, Omar S. Aljitawi, Michael W. Becker, Jason H. Mendler, Heidi D. Klepin,...> ;Biology of Blood and Marrow Transplantation. 2020 Dec 1
• 6 citations
  Unraveling the Origin of the Long Fluorescence Decay Component of Cesium Lead Halide Perovskite Nanocrystals.
  Michael Becker, Caterina Bernasconi, Maryna I. Bodnarchuk, Gabriele Rainò, Maksym V. Kovalenko, David J. Norris, Rainer F. Mahrt, Thilo Stöferle> ;ACS Nano. 2020 Nov 11
• 8 citations
  Decisional involvement and information preferences of patients with hematologic malignancies
  Kah Poh Loh, Mazie Tsang, Thomas W. LeBlanc, Anthony L. Back, Paul R. Duberstein, Supriya G. Mohile, Ronald M. Epstein, Heidi D. Klepin, Michael W. Becker, Areej El-Ja...> ;Blood Advances. 2020 Nov 10
• 110 citations
  Nicotinamide Metabolism Mediates Resistance to Venetoclax in Relapsed Acute Myeloid Leukemia Stem Cells
  Courtney L. Jones, Brett M. Stevens, Daniel A. Pollyea, Rachel Culp-Hill, Julie A. Reisz, Travis Nemkov, Sarah Gehrke, Fabia Gamboni, Anna Krug, Amanda Winters, Shansh...> ;Cell Stem Cell. 2020 Nov 5
• 121 citations
  Fatty acid metabolism underlies venetoclax resistance in acute myeloid leukemia stem cells
  Brett M. Stevens, Courtney L. Jones, Daniel A. Pollyea, Rachel Culp-Hill, Angelo D'Alessandro, Amanda Winters, Anna Krug, Diana Abbott, Madeline Goosman, Shanshan Pei,...> ;Nature Cancer. 2020 Oct 26
• 16 citations
  Global Longitudinal Strain at Rest as an Independent Predictor of Mortality in Liver Transplant Candidates: A Retrospective Clinical Study.
  Mare Mechelinck, Bianca Hartmann, Sandra Hamada, Michaël De Becker, Anne Andert, Tom Florian Ulmer, Ulf P. Neumann, Theresa H. Wirtz, Alexander Koch, Christian Trautwe...> ;Journal of Clinical Medicine. 2020 Aug 12
• 13 citations
  Trion Emission Dominates the Low-Temperature Photoluminescence of CdSe Nanoplatelets.
  Felipe V. Antolinez, Freddy T. Rabouw, Aurelio A. Rossinelli, Robert C. Keitel, Ario Cocina, Michael Becker, David J. Norris> ;Nano Letters. 2020 Jun 26
• 1 citations
  Non-donor specific anti-human leukocyte antigen (HLA) antibodies are not associated with poor outcome in hematopoietic stem cell transplant recipients.
  Jeffrey R. Andolina, R. Walia, Jamie Oliva, Andrea Baran, Jane L. Liesveld, Michael W. Becker, Angela Busacco, Myra Coppage> ;Human Immunology. 2020 May 26
• Join now to see all

Journal Articles

• SWOG S0910: a phase 2 trial of clofarabine/cytarabine/epratuzumab for relapsed/refractory acute lymphocytic leukaemia  
  Advani AS, McDonough S, Coutre S, Wood B, Radich J, Mims M, O'Donnell M, Elkins S, Becker M, Othus M, Appelbaum FR, Br J Haematol, 1/1/2014
• Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myeloid leukemia  
  Guzman ML, Yang N, Sharma KK, Balys M, Corbett CA, Jordan CT, Becker MW, Steidl U, Abdel-Wahab O, Levine RL, Marcucci G, Roboz GJ, Hassane DC, Mol Cancer Ther, 1/1/2014
• Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells  
  Pei S, Minhajuddin M, Callahan KP, Balys M, Ashton JM, Neering SJ, Lagadinou ED, Corbett C, Ye H, Liesveld JL, O'Dwyer KM, Li Z, Shi L, Greninger P, Settleman J, Benes..., J Biol Chem, 1/22/2013
• Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity  
  Sen S, Hassane DC, Corbett C, Becker MW, Jordan CT, Guzman ML, Exp Hematol, 1/1/2013
• The hematopoietic cell transplantation specific comorbidity index and survival after extracorporeal photopheresis, pentostatin, and reduced dose total body irradiation...  
  Hashmi S, Oliva JL, Liesveld JL, Phillips GL 2nd, Milner L, Becker MW, Leuk Res, 1/1/2013
• Defining patient-specific risk in acute myeloid leukemia  
  Ho TC, Becker MW, J Clin Oncol, 1/1/2013
• A phase 1 trial of eltrombopag in patients undergoing stem cell transplantation after total body irradiation  
  Liesveld JL, Phillips GL 2nd, Becker M, Constine LS, Friedberg J, Andolina JR, Milner LA, Debolt J, Smudzin T, Hyrien O, Erickson-Miller CL, Johnson BM, Dawson KL, Che..., Biol Blood Marrow Transplant, 1/1/2013
• A phase I study of decitabine and rapamycin in relapsed/refractory AML  
  Liesveld JL, O'Dwyer K, Walker A, Becker MW, Ifthikharuddin JJ, Mulford D, Chen R, Bechelli J, Rosell K, Minhajuddin M, Jordan CT, Phillips GL 2nd, Leuk Res, 1/1/2013
• Prostaglandin E2 increases hematopoietic stem cell survival and accelerates hematopoietic recovery after radiation injury  
  Porter R.L., M. Georger, O. Bromberg, K.E. McGrath, B.J. Frisch, M. W. Becker and L. M. Calvi, Stem Cells, 1/21/2012
• Late Relapses following High-Dose Autologous Stem Cell Transplantation (HD-ASCT) for Hodgkin's Lymphoma (HL) in the ABVD Therapeutic Era  
  Keller SF, Kelly JL, Sensenig E, Andreozzi J, Oliva J, Rich L, Constine L, Becker M, Phillips G, Liesveld J, Fisher RI, Bernstein SH, Friedberg JW, Biol Blood Marrow Transplant, 1/1/2012
• A Phase I trial of dose escalation of Melphalan in the "BEAM" regimen using Amifostine cytoprotection  
  Phillips, G.L., Bernstein, S.H., Liesveld, J.L., Abboud, C.N., Becker, M.W., Constine, L.S., Ifthikharuddin, J.J., Loughner, J.E., Milner, L.A., Vesole, D.H., Friedber..., Biol Blood Marrow Transplant, 1/1/2011
• Intra-arterial methylprednisolone for the management of steroid-refractory acute gastrointestinal and hepatic graft versus host disease  
  Milner LA, Becker MW, Bernstein SH, Bruckner L, Friedberg JW, Holland GA, Ifthikharuddin JJ, Liesveld JL, Mathes EJ, Menchel HL, Mullen CA, Sasson T, Phillips GL 2nd, Am J Hematol, 1/1/2011
• Leukemia Stemness Signatures Step toward the Clinic  
  Becker, MW and Jordan, C.T., Cell Stem Cell, 1/1/2011
• Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia  
  Frisch B.J., John M. Ashton J.M., Xing L.P., Becker M.W., Jordan C.T. and L. M. Calvi, Blood, 1/1/2011
• Reviews: The Leukemia stem cells in 2010: current understanding and future directions  
  Becker, M.W. and Jordan, C.T., Blood Rev, 1/1/2011
• Is consolidation chemotherapy necessary before non-myeloablative transplantation in AML?  
  Hashmi S, Becker M, Leuk Res, 1/1/2011
• An evolutionarily conserved PTEN-C/EBP{ALPHA}-CTNNA1 axis controls myeloid development and transformation  
  Fu CT, Zhu KY, Mi JQ, Liu YF, Murray ST, Fu YF, Ren CG, Dong ZW, Liu YJ, Dong M, Jin Y, Chen Y, Deng M, Zhang W, Chen B, Breslin P, Chen SJ, Chen Z, Becker MW, Zhu J, ..., Blood, 1/6/2010
• Dysregulated gene expression networks in human acute myelogenous leukemia stem cells  
  Majeti R, Becker MW, Tian Q, Lee TL, Yan X, Liu R, Chiang JH, Hood L, Clarke MF, Weissman IL, Proc Natl Acad Sci USA, 1/1/2009
• Phase I study of cladribine, cytarabine (Ara-C), granulocyte colony stimulating factor (G-CSF) (CLAG Regimen) and simultaneous escalating doses of imatinib mesylate (G...  
  Walker, A.R., Komrokji, R.S., Ifthikharuddin, J., Messina P, Mulford D, Becker M, Friedberg J, Oliva J, Phillips G, Liesveld JL, Abboud C., Leuk Res, 1/1/2008
• Chromosome 5q deletionand epigenetic suppression of the gene encoding alpha-catenin (CTNNA1) in myeloid cell transformation  
  Liu, T.X., Becker, M.W., Jelinek, J., Wu, W.S., Deng, M., Mikhalkevich, N., Hsu, K., Bloomfield, C.D., Stone, R.M., DeAngelo, D.J., Galinsky, I.A., Issa, J.P., Clarke,..., Nat Med, 1/1/2007
• An orally bioavailable parthenolide analog selectively eradicates acutemyelogenous leukemia stem and progenitor cells  
  Guzman, M.L., Rossi, R.M., Neelakantan S., Li, X., Corbett, C.A., Hassane, D.C., Becker, M.W., Bennett, J.M., Sullivan, E., Lachowicz, J.L., Vaughan, A., Sweeney, C.J...., Blood, 1/1/2007
• Pilot Trial on the Use of Etanercept and Methylprednisolone as Primary Treatment for Acute Graft-versus-Host Disease  
  Uberti JP, Ayash L, Ratanatharathorn V, Silver S, Reynolds C, Becker M, Reddy P, Cooke KR, Yanik G, Whitfield J, Jones D, Hutchinson R, Braun T, Ferrara JL, Levine JE, Biol Blood Marrow Transplant, 1/1/2005
• Therapeutic implications of cancer stem cells  
  Al-Hajj M., Becker M.W., Wicha M., Weissman I., Clarke M.F., Current Opinion in Genetics & Development, 1/1/2004
• Bmi1 is required for adult hematopoietic stem cell self renewal  
  Park, I, Qian, D., Kiel, M, Becker, M.W., Pihalja, M., Weissman, IL, Morrison, I.L. and Clarke, M.F., Nature, 1/1/2003
• Treatment of chronic graft-versus-host disease with anti-Cd20 chimeric monoclonal antibody  
  Ratanatharathorn, V., Ayash, L., Reynolds, C., Silver, S., Reddy, P., Becker, M.W., Ferrara, J.l., Uberti, J.P., Biol Blood Marrow Transplant, 1/1/2003
• Join now to see all

Books/Book Chapters

• Cancer Stem Cells: Emerging Concepts and Future Perspectives in Translational Oncology 
  Chapter: Leukemic and lymphoid stem cells. 
  Becker, M.W. and O'Dwyer, K.M.Springer Health, London2015

Abstracts/Posters

• A Specific Mesenchymal Stem and Progenitor Cell (MSPC) Subpopulation with a Multi-Potent Gene Signature Is Transcriptionally Altered in the Setting of Myelodysplastic ...
  Michael W. Becker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Increased Early Mortality after Fludarabine and Melphalan Conditioning with Peripheral Blood Grafts in Haploidentical SCT with Post-Transplant Cyclophosphamide
  Michael W. Becker, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Disruption Of The Hematopoietic Stem and Progenitor Cell Pool and Bone Marrow Microenvironment In a Murine Model Of Myelodysplastic Syndrome.
  Balderman, S. R., Frisch, B.J., LaMere, M.W., Goodman, A.N.., Becker, M.W. and Calvi, L.M., American Society of Hematology Annual Meeting, 1/1/2014
• Clinical and Biologic Effects Of The Angiopoietin 1/2 Neutralizing Peptibody, Trebananib (AMG 386), In Acute Myeloid Leukemia Patients.
  Wang, E.S., Fetterly, G., Brady, W., Tan, W., Greene, J., Gaudy, A., Vigil, C.E., Mendler, J.M., Becker, M.W., O'Dwyer, K.M., Liesveld, J.L., Wetzler, M., American Society of Hematology Annual Meeting, 1/1/2014
• The Significance of GADD45A Promoter DNA Hypermethylation in AML: Association with IDH1/2 and TET2 Mutation.
  Perugini, M. Samaraweera, S.E., Brown, A.L, Cummings, N., Danner, S., Tiong, I.S., Garrett-Bakelman, F.E., Carroll, M.P., Becker, M.W., Chung, S.S, Park, C.Y., Mason, ..., American Society of Hematology Annual Meeting, 1/1/2014
• Administration of High Dose BEAM Chemotherapy As Conditioning for Autologous Stem Cell Transplantation for Lymphoma Results in Fewer Infectious Complications and Impro...
  Reid, R.M., Baran, A., Barr, P.M., Becker, M.W., Bernstein, S.H., Friedberg, J.W., Liesveld, J.L., Phillips, G.W., Wedow, L., Milner, L.A., American Society of Hematology Annual Meeting, 1/1/2014
• Late Relapses Following High Dose Chemotherapy and Autologous Stem Cell Transplant in Patients with Diffuse Large B Cell Lymphoma in the Rituximab Era.
  Carla Casulo, C., Bradley, H.D., Herr, M.H., Barlaskar, F., Evans, A., Burack, R., Liesveld, J.L., Becker, M.W., Milner, L.A., Barr, P.M., Friedberg, J.W., American Society of Hematology Annual Meeting, 1/1/2014
• Modulation of Interaction of Human Osteoprogenitor Cells with Hematopoietic Stem and Progenitor Cells.
  Akwaa, F., Rubinova, R., Frisch, B.J., LaMere, M.W., O'Dwyer, K.M., Liesveld, J.L. Becker, M.W. and Calvi, L.M., American Society of Hematology Annual Meeting, 1/1/2014
• Microenvironmental Contribution to Dysfunctional Hematopoiesis in a Murine Model of Myelodysplastic Syndrome.
  Balderman, S. R., Frisch, B.J., LaMere, M.W., Goodman, A.N.., Becker, M.W. and Calvi, L.M., American Society of Hematology Annual Meeting, 1/1/2014
• Evolution of Acute Myelogenous Leuekmia Stem Cell Properties Following Treatment and Progression.
  Ho, T LaMere, M., Jordan, CT., and Becker, M.W., FASEB, Hematologic Malignaices, 1/1/2013
• Evolution of Acute Myelogenous Leuekmia Stem Cell Properties Following Treatment and Progression.
  Ho, T., LaMere, M.W., O'Dwyer, K., Mendler, J.M., Liesveld, J.L., Wetzler, M., Wang, E.S., Guzman, M.L., Jordan, C.T., Becker, M.W., American Society of Hematology Annual Meeting, 1/1/2013
• Epigenetic Deregulation In Relapsed Acute Myeloid Leukemia.
  Garrett-Bakelman, FE., Li, S., Hricik, T., Chung, S., Bar, H., Brown, A.L., Patel, J.P., Rapoport, F., Liu, L., Sheridan, C., Ishii, J., Zumbo, P., Gandara, J., Lewis,..., American Society of Hematology Annual Meeting, 1/1/2013
• HSP70 Inhibitor, YK5, Ablates Blast, Progenitor and Stem Cell Populations in Primary Acute Myelogenous Leukemia Cells.
  Rico, J.P., Sharma, K.K., Kang, Y., Taldone, T., Patel, H., Brennan, Zong, H., Becker, M.W., Roboz, G. J., Chiosis, G., Guzman, M.L., American Society of Hematology Annual Meeting, 1/1/2012
• The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Ir...
  Hashmi, ., Oliva, J.L., Liesveld, J.L., Phillips, G.L. Nichols, D. and Becker, M.W., American Society of Bone Marrow Transplantation, 1/1/2012
• Southwest Oncology Group Study S0910: A Phase 2 Trial of Clofarabine/ Cytarabine/ Epratuzumab for Relapsed/ Refractory Acute Lymphocytic Leukemia.
  Advani, A., McDonough, S., Coutre, S., Brent L. Wood, B.L., Radich, J.P., Mims, M., O'Donnell, M., Elkins, S., Becker, M.W., Othus, M., Appelbaum, F.R., American Society of Hematology Annual Meeting, 1/1/2012
• Phase I Study of Eltrombopag for Promoting Thrombopoiesis in Patients Undergoing Stem Cell Transplantation After Total Body Irradiation.
  Liesveld JL, Phillips GL 2nd, Becker M.W, Constine LS, Friedberg J, Andolina JR, Milner LA, Smudzin T, Hyrien O, Dawson KL, Chen Y., American Society of Hematology Annual Meeting, 1/1/2012
• Phase I Study of Decitabine and Rapamycin in Relapsed/Refractory Acute Myelogenous Leukemia.
  Liesveld JL, O'Dwyer K, Becker M.W., Mulford D, Walker A, Chen R, Bechelli J, Rosell K, Jordan CT, Minhajuddin M, Phillips GL 2nd, American Society of Hematology Annual Meeting, 1/1/2012
• HSP70 Inhibitor, YK5, Synergizes with Chemotherapeutic Agents and Prevents Chemoresistance in Acute Myelogenous Leukemia (AML).
  Sharma, K.K., Rico, J.P., Becker, M.W., Roboz, G. J., Chiosis, G., Guzman, M.L., American Society of Hematology Annual Meeting, 1/1/2012
• Bcl-2 Inhibitor ABT-263 Targets Oxidative Phosphorylation and Selectively Eradicates Quiescent Human Leukemia Stem Cell.
  Lagadinou ED, Sach A, Callahan K, Rossi RM, Neering SJ, Pei S, O'Dwyer KM, Liesveld JL, Brookes PS, Becker M.W., Jordan CT, American Society of Hematology Annual Meeting, 1/1/2012
• Targeting Redox Homeostasis As a Means to Selectively Eradicate Primary Human Leukemia Cells.
  Pei S, Callahan KP, Minhajuddin M, Balys M, Neering SJ, Corbett C, Becker M.W., Liesveld JL, Hagen FK, Friedman, A.E., , Crooks PA, Jordan CT, American Society of Hematology Annual Meeting, 1/1/2011
• The Hematopoietic Cell Transplantation-Specific Comorbidity Index (HCT-CI) and Survival After Extracorporeal Photopheresis, Pentostatin, and Reduced Dose Total Body Ir...
  Hashmi, ., Oliva, J.L., Liesveld, J.L., Phillips, G.L. Nichols, D. and Becker, M.W., American Society of Hematology Annual Meeting, 1/1/2010
• High-Dose Therapy and Autologous Stem Cell Transplant (HD-ASCT) for Transformed Non-Hodgkin Lymphoma (NHL) In the Rituximab Era.
  Ban-Hoefen M, Friedberg JW., Kelly JL, Bernstein SH, Liesveld J, Young, F., Fisher, R.I., Constine L, Becker M.W., Phillips G, American Society of Hematology Annual Meeting, 1/1/2010
• Alpha-Catenin Is Dispensable for Normal Hematopoietic Stem Cell Function.
  Mikhalkevich, N., Becker, M.W., American Society of Hematology Annual Meeting, 1/1/2009
• Epigenetic Suppression of the CTNNA1 Gene, Encoding the alpha-Catenin Protein, which Is Located in the 5q31 Critical Deleted Region in Malignant Myeloid Disorders with...
  Liu, T.X., Becker, M.W., Hsu, K., Jelinek, J., Deng, D., Bloomfield, C., Issa, J.P., Clarke, M.F., Look, A.T., American Society of Hematology Annual Meeting, 1/1/2004
• Reduced Intensity Regimen for Unrelated Donor Transplantation (UDT) as Salvage Therapy for Prior Recipients of Autologous Stem Cell Transplantation.
  Ratanatharathorn, V., Ayash, L., Silver, S., Reynolds, C., Becker, M.W., Reddy, P., Uberti, J.P., American Society of Hematology Annual Meeting, 1/1/2003
• Join now to see all

Lectures

• Qualitative Study of Factors That Influence Treatment Decision-Making Among Community Oncologists and Older Patients with Acute Myeloid Leukemia 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Access and Referral Barriers to Autologous and Allogeneic Hematopoietic Cell Transplantation in Adult Patients with Cancer: A Systematic Review with a Specific Focus o... 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018

Other

• Stem Cells: Finding the Real Culprits in Cancer. 
  Clarke, M.F., and Becker, M.W.
  1/1/2006